Plasma haemostatic potential of haemodialysis patients assessed by thrombin generation assay: Hypercoagulability in patients with vascular access thrombosis

Thrombosis Research

Volumn 132, Issue 5, 2013, Pages 604-609

  Jeong, Jong Cheol ^a   Kim, Ji Eun ^a   Ryu, Ji Won ^a   Joo, Kwon Wook ^a   Kim, Hyun Kyung ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Antiplatelet agent; End stage renal disease; Haemodialysis; Thrombin generation assay; Vascular access thrombosis

Indexed keywords

ACTIVATED PROTEIN C; ANTICOAGULANT AGENT; APC PROTEIN; THROMBIN; THROMBOMODULIN; THROMBOPLASTIN;

ADULT; AGED; ARTICLE; ASSAY; CALIBRATION; CLINICAL ASSESSMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBIN GENERATION ASSAY; THROMBIN TIME; THROMBOCYTE POOR PLASMA; THROMBOSIS; VASCULAR ACCESS;

ANTIPLATELET AGENT; END-STAGE RENAL DISEASE; HAEMODIALYSIS; THROMBIN GENERATION ASSAY; VASCULAR ACCESS THROMBOSIS;

AGED; BLOOD COAGULATION TESTS; FEMALE; HEMOSTASIS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; THROMBIN; THROMBOPHILIA; THROMBOSIS;

EID: 84886094651     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.09.002     Document Type: Article

References (38)

1. N.D. Vaziri, E.C. Gonzales, J. Wang, and S. Said Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: effect of hemodialysis Am J Kidney Dis 23 1994 828 835
2. D. Molino, D. De Lucia, R. Marotta, A. Perna, C. Lombardi, and M. Cirillo In uremia, plasma levels of anti-protein C and anti-protein S antibodies are associated with thrombosis Kidney Int 68 2005 1223 1229
3. H.L. Daneschvar, A. Seddighzadeh, G. Piazza, and S.Z. Goldhaber Deep vein thrombosis in patients with chronic kidney disease Thromb Haemost 99 2008 1035 1039
4. M.R. Nampoory, K.C. Das, K.V. Johny, N. Al-Hilali, M. Abraham, and S. Easow Hypercoagulability, a serious problem in patients with ESRD on maintenance hemodialysis, and its correction after kidney transplantation Am J Kidney Dis 42 2003 797 805
5. M.J. Adams, A.B. Irish, G.F. Watts, R. Oostryck, and G.K. Dogra Hypercoagulability in chronic kidney disease is associated with coagulation activation but not endothelial function Thromb Res 123 2008 374 380
6. S.J. Jubelirer Hemostatic abnormalities in renal disease Am J Kidney Dis 5 1985 219 225
7. J. Himmelfarb, S. Nelson, E. McMonagle, D. Holbrook, S.E. Benoit, and A.D. Michelson Elevated plasma glycocalicin levels and decreased ristocetin-induced platelet agglutination in hemodialysis patients Am J Kidney Dis 32 1998 132 138
8. A. Tripodi, C. Legnani, V. Chantarangkul, B. Cosmi, G. Palareti, and P.M. Mannucci High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism J Thromb Haemost 6 2008 1327 1333
9. R. Al Dieri, F. Peyvandi, E. Santagostino, M. Giansily, P.M. Mannucci, and J.F. Schved The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding Thromb Haemost 88 2002 576 582
10. G. Hron, M. Kollars, B.R. Binder, S. Eichinger, and P.A. Kyrle Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation JAMA 296 2006 397 402
11. T. Matsumoto, M. Shima, M. Takeyama, K. Yoshida, I. Tanaka, and Y. Sakurai The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay J Thromb Haemost 4 2006 377 384
12. P. Simioni, E. Castoldi, B. Lunghi, D. Tormene, J. Rosing, and F. Bernardi An underestimated combination of opposites resulting in enhanced thrombotic tendency Blood 106 2005 2363 2365
13. Y. Dargaud, M.C. Trzeciak, J.C. Bordet, J. Ninet, and C. Negrier Use of calibrated automated thrombinography +/- thrombomodulin to recognise the prothrombotic phenotype Thromb Haemost 96 2006 562 567
14. A. Brandts, A. van Hylckama Vlieg, J. Rosing, T.P. Baglin, and F.R. Rosendaal The risk of venous thrombosis associated with a high endogenous thrombin potential in the absence and presence of activated protein C J Thromb Haemost 5 2007 416 418
15. E. Castoldi, J.W. Govers-Riemslag, M. Pinotti, D. Bindini, G. Tans, and M. Berrettini Coinheritance of Factor V (FV) Leiden enhances thrombin formation and is associated with a mild bleeding phenotype in patients homozygous for the FVII 9726 + 5G > A (FVII Lazio) mutation Blood 102 2003 4014 4020
16. Y. Dargaud, S. Beguin, A. Lienhart, R. Al Dieri, C. Trzeciak, and J.C. Bordet Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B Thromb Haemost 93 2005 475 480
17. Standards of medical care in diabetes - 2011 Diabetes Care 34 Suppl. 1 2011 S11 S61
18. J.W. Seo, H.K. Kim, J.E. Kim, S. Park, and H.I. Cho Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation Thromb Res 123 2009 565 572
19. R.M. Holden, G.J. Harman, M. Wang, D. Holland, and A.G. Day Major bleeding in hemodialysis patients Clin J Am Soc Nephrol 3 2008 105 110
20. J. Duchemin, B. Pan-Petesch, B. Arnaud, M.T. Blouch, and J.F. Abgrall Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma Thromb Haemost 99 2008 767 773
21. P.M. Ambuhl, R.P. Wuthrich, W. Korte, L. Schmid, and R. Krapf Plasma hypercoagulability in haemodialysis patients: impact of dialysis and anticoagulation Nephrol Dial Transplant 12 1997 2355 2364
22. R.D. Frank, J. Weber, H. Dresbach, H. Thelen, C. Weiss, and J. Floege Role of contact system activation in hemodialyzer-induced thrombogenicity Kidney Int 60 2001 1972 1981
23. A. Darlington, J.L. Ferreiro, M. Ueno, Y. Suzuki, B. Desai, and P. Capranzano Haemostatic profiles assessed by thromboelastography in patients with end-stage renal disease Thromb Haemost 106 2011 67 74
24. H. Takahashi, K. Wada, H. Niwano, and A. Shibata Comparison of prothrombin fragment 1 + 2 with thrombin-antithrombin III complex in plasma of patients with disseminated intravascular coagulation Blood Coagul Fibrinolysis 3 1992 813 818
25. C.S. Kitchens To bleed or not to bleed? Is that the question for the PTT? J Thromb Haemost 3 2005 2607 2611
26. H.C. Hemker, P. Giesen, R. Al Dieri, V. Regnault, E. de Smedt, and R. Wagenvoord Calibrated automated thrombin generation measurement in clotting plasma Pathophysiol Haemost Thromb 33 2003 4 15
27. S. Wielders, M. Mukherjee, J. Michiels, D.T. Rijkers, J.P. Cambus, and R.W. Knebel The routine determination of the endogenous thrombin potential, first results in different forms of hyper- and hypocoagulability Thromb Haemost 77 1997 629 636
28. P.A. Kyrle, C. Mannhalter, S. Beguin, A. Stumpflen, M. Hirschl, and A. Weltermann Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene Arterioscler Thromb Vasc Biol 18 1998 1287 1291
29. W.C. Winkelmayer Tackling the Achilles' heel of hemodialysis N Engl J Med 364 2011 372 374
30. R.D. Swartz, J.M. Messana, C.J. Boyer, N.M. Lunde, W.F. Weitzel, and T.L. Hartman Successful use of cuffed central venous hemodialysis catheters inserted percutaneously J Am Soc Nephrol 4 1994 1719 1725
31. S.O. Trerotola, M.S. Johnson, V.J. Harris, H. Shah, W.T. Ambrosius, and M.A. McKusky Outcome of tunneled hemodialysis catheters placed via the right internal jugular vein by interventional radiologists Radiology 203 1997 489 495
32. A. Mina, E.J. Favaloro, and J. Koutts Relationship between short activated partial thromboplastin times, thrombin generation, procoagulant factors and procoagulant phospholipid activity Blood Coagul Fibrinolysis 23 2012 203 207
33. M. Montagnana, T. Meschi, L. Borghi, and G. Lippi Thrombosis and occlusion of vascular access in hemodialyzed patients Semin Thromb Hemost 37 2011 946 954
34. E. Castoldi, and J. Rosing APC resistance: biological basis and acquired influences J Thromb Haemost 8 2010 445 453
35. T.W. Kim, W.K. Kim, J.H. Lee, S.B. Kim, S.W. Kim, and C. Suh Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis J Korean Med Sci 13 1998 587 590
36. S.P. Jackson, and S.M. Schoenwaelder Antiplatelet therapy: in search of the 'magic bullet' Nat Rev Drug Discov 2 2003 775 789
37. A. Undas, K.E. Brummel-Ziedins, and K.G. Mann Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions Blood 109 2007 2285 2292
38. A. Undas, W.J. Sydor, K. Brummel, J. Musial, K.G. Mann, and A. Szczeklik Aspirin alters the cardioprotective effects of the factor XIII Val34Leu polymorphism Circulation 107 2003 17 20